definiens: shall mean the research, development and / orcommercialization of any HDAC Inhibitor(s ) ( other than a Compound ), or anyproduct(s ) containing same, in any particular disease area other than the Cancer Field and the Field, in respect of which such licensee or sublicensee, or any of its Affiliates, is, at 7 any time and from time to time, taking any part whatsoever, either directly or indirectly, providedthat such HDAC Inhibitor(s ) shall not exploit, infringe upon or misappropriate any of the LicensedMethylGene Patent Rights, Licensed [COMPANY] Technology, EVP Licensed Patent Rights or EVPLicensed Technology ; and ( f ) The licensee or sublicensee shall covenant that any further licensee or sublicense granted by it to aThird Party shall be subject to each and every one of the Licensing Conditions